8-K ·Filed Jun 9, 2026

QTRX

Quanterix Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001628280-26-041773
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

Routine CFO appointment with no financial guidance or operational update. Monitor next quarterly earnings for any strategic shifts under the new CFO. The equity grant represents modest dilution (~0.30%) and is not a material event.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
QTRX ▼ -15.53% at T+60d
NEUTRAL call ✗ call lost -15.53% · α vs SPY -19.35% · entry $3.09 → $2.61
Entry anchored
Jun 8, 03:59 PM ET
via exchange tick
T+1d
-0.65%
call -0.65% · α +0.93%
$3.07
settled 4mo ago
T+5d
+0.32%
call +0.32% · α -2.09%
$3.10
settled 4mo ago
T+20d
+29.45%
call +29.45% · α +28.00%
$4.00
settled 3mo ago
T+60d
-15.53%
call -15.53% · α -19.35%
$2.61
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Quanterix appointed Jason Faessler as CFO, effective June 22, 2026, replacing the prior CFO. Faessler joins from Bruker Corporation with a compensation package including a $475,000 base salary, $200,000 cash sign-on bonus, and an equity award of ~140k RSUs (0.30% of shares outstanding). This is a routine executive appointment with no financial results or guidance provided.

Key Facts

  • Jason Faessler appointed CFO and Treasurer, effective June 22, 2026
  • Annual base salary of $475,000
  • Cash sign-on bonus of $200,000
  • Annual bonus target of 50% of base salary
  • Sign-on equity award of ~140k RSUs (0.30% of fully diluted shares outstanding), vesting over 4 years
  • Faessler previously SVP of Finance at Bruker Corporation

Financial Impact

Total first-year cash compensation of $475,000 salary + $200,000 sign-on bonus = $675,000; equity award of ~140k RSUs at ~$147M market cap represents ~$440k at current valuation (0.30% dilution).

dilution

Risk Factors

  • No prior CFO departure reason disclosed; potential for undisclosed internal issues
  • Equity dilution from sign-on RSUs (~0.30% of shares outstanding)

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-041773
Exhibit: exhibit991-qtrxx20260609.htm0001628280-26-041773
Document: qtrx-20260609.htm0001628280-26-041773
Document: 0001628280-26-041773-index-headers.html0001628280-26-041773
Document: 0001628280-26-041773-index.html0001628280-26-041773
Document: 0001628280-26-041773.txt0001628280-26-041773
5 reports for QTRX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for QTRX — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
BEARISH ★ 8/10
$2.42 $2.73▼ −12.81%▼ −13.72%$3.41 (−40.91%)
Jun 17, 2026
15w ago
Institutional Cluster
BULLISH ★ 5/10
$2.88 $3.96▲ +37.50%▲ +36.18%$3.41 (+18.40%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$3.09 $4.00▲ +29.45%▲ +28.00%$3.41 (+10.36%)
May 26, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$2.65 $3.76▲ +41.89%▲ +43.79%$3.41 (+28.68%)
May 8, 2026
21w ago
DEFA14A
NEUTRAL ★ 2/10
$2.80 $3.09▲ +10.36%▲ +10.66%$3.41 (+21.79%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (37h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access